Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

<< Previous

Bullboard Posts

Next >>

Post by SPCEO1on Apr 13, 2023 11:19pm

224 Views

Post# 35394487

Unity Biotechnology?

Just a weird little mistake - if you download the corporate presentation, the title of the file is Unity Biotechnology. Evidently, THTX must be hiring some consultant to put together their corporate presentation (which have improved a lot in the last two years) and that consultant forgot to change the name of the file before sending it onto THTX and THTX did not pick up on it either.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China